These may range from in-body and therapeutic procedures to highly specialized tubing for pharmaceutical and biopharma production.

Once the procedure is set, the outcome is very consistent.

The parties agree that Seller need not further object to any specific terms and conditions set by Buyer; such failure to object to Buyer’s specific terms and conditions is not an acceptance of any such terms and conditions. In no event shall Seller be liable for any damages and/or costs due to delay in delivery. Except to the extent solely attributable to the gross negligence or willful misconduct of Seller, Buyer will indemnify, defend and hold Seller harmless from all costs, expenses, damages, judgments or other loss, including without limitation costs of investigation, litigation and reasonable attorney’s fees (“Buyer Indemnity Costs”), arising out of Buyer’s selection, use, sale or further processing of the Product or Buyer’s product made therefrom.

Shielding connectors deliver higher speeds, lower costs than ever before A cost-effective solution that would enable the manufacturer to compete in this new market    The Avient material met the targeted cost and performance targets

The parties agree that Seller need not further object to any specific terms and conditions set by Buyer; such failure to object to Buyer’s specific terms and conditions is not an acceptance of any such terms and conditions. In no event shall Seller be liable for any damages and/or costs due to delay in delivery. Except to the extent solely attributable to the gross negligence or willful misconduct of Seller, Buyer will indemnify, defend and hold Seller harmless from all costs, expenses, damages, judgments or other loss, including without limitation costs of investigation, litigation and reasonable attorney’s fees (“Buyer Indemnity Costs”), arising out of Buyer’s selection, use, sale or further processing of the Product or Buyer’s product made therefrom.

The parties agree that Seller need not further object to any specific terms and conditions set by Buyer; such failure to object to Buyer’s specific terms and conditions is not an acceptance of any such terms and conditions. In no event shall Seller be liable for any damages and/or costs due to delay in delivery. Except to the extent solely attributable to the gross negligence or willful misconduct of Seller, Buyer will indemnify, defend and hold Seller harmless from all costs, expenses, damages, judgments or other loss, including without limitation costs of investigation, litigation and reasonable attorney’s fees (“Buyer Indemnity Costs”), arising out of Buyer’s selection, use, sale or further processing of the Product or Buyer’s product made therefrom.

Compliance with UK tax laws, rules and regulations The Avient Group respects and obeys the laws, rules, and regulations for all jurisdictions where the Avient Group operates. As such, the Avient Group is committed to observing and complying with all applicable UK tax laws, rules, and regulations.

A high productivity manufacturing process that drives low per-part cost is crucial for dealing with cost pressures. Reduce Total System Cost TPEs work to reduce costs in other ways too.

Notwithstanding any provision to the contrary, Seller shall be entitled to first credit payments against Buyer's old debts, and in the following order: costs, interests and lastly main obligation. Except to the extent attributable to the Product sold hereunder failing to meet the express warranties set forth in paragraph 2, Buyer will indemnify, defend and hold Seller harmless from all costs, expenses, damages, judgements or other loss, including costs of investigation, litigation and reasonable attorney's fees, arising out of Buyer's selection, use, sale and further processing of the Product sold hereunder. In the event that a provision of these Terms and Conditions is ruled invalid or inapplicable, this shall not affect the validity of the remaining provisions. 17.

In particular, these include statements relating to future actions; prospective changes in raw material costs, product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings and environmental liabilities; and financial results. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; • The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without any limitation, any supply chain and logistics issues; • Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; • Fluctuations in raw material prices, quality and supply, and in energy prices and supply; • Production outages or material costs associated with scheduled or unscheduled maintenance programs; • Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • Information systems failures and cyberattacks; • Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; • Any material adverse changes in the equity and assets of Koninklijke DSM N.V.’s protective materials business (“the Dyneema Business”); • Our ability to achieve the strategic and other objectives relating to the acquisition of the Dyneema Business and the possible sale of the Distribution business segment; and • Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2021 and our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2022 under Item 1A, “Risk Factors.” This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition-related costs, and other non-routine costs.